|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 414.60 DKK | -2.22% |
|
-5.55% | -33.58% |
| 07-18 | Fangzhou Inc. and Novo Nordisk Signs Collaboration Memorandum to Establish A New Ecosystem for Health Management | CI |
| 07-18 | NOVO NORDISK : UBS keeps its Buy rating | ZD |
Evolution of the Average Target: Novo Nordisk A/S
Evolution of the Target Price: Novo Nordisk A/S
Changes in Analyst Recommendations: Novo Nordisk A/S
069736481bf09bcd93fd.U9YOL4dNGzaYEqeuZWhymwPXLpJX6JbbwjO6iW2g044.Nq9javR6VFLvXtbnLSwq11GEa9Ezhqe09wHSzADUqsliiUJq5DxLb-F-6g~c32d24ab0c1a6bc5cca8bd469ed09a43
More recommendations
| Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +55.34% | ||||||
| +23.4% | ||||||
| +6.56% | ||||||
| +10.52% | ||||||
| +16.31% | ||||||
| - | +5.22% | |||||
| +33.22% | ||||||
| +27.3% | ||||||
| +6.38% | ||||||
| +19.45% | ||||||
| Average | +20.37% | |||||
| Weighted average by Cap. | +20.64% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
414.60DKK
Average target price
644.05DKK
Spread / Average Target
+55.34%
High Price Target
900.00DKK
Spread / Highest target
+117.08%
Low Price Target
405.00DKK
Spread / Lowest Target
-2.32%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| UBS | |
| BERENBERG | |
| DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
| JPMORGAN | Richard Vosser |
| JEFFERIES | Benjamin Jackson |
| BARCLAYS | Emily Field |
| BERNSTEIN RESEARCH | Florent Cespedes |
| alphavalue | Abhishek Raval |
| GOLDMAN SACHS | James Quigley |
| DZ BANK | Elmar Dr. Kraus |
| BMO Capital | |
| BNP Paribas Exane | |
| Kepler Cheuvreux | |
| Stifel Nicolaus | |
| Jyske Bank | |
| BNP Paribas | |
| ODDO BHF | |
| Svenska Handelsbanken | |
| AlphaValue/Baader Europe | |
| Argus | |
| Cantor Fitzgerald | |
| TD Cowen | |
| Berenberg Bank | |
| CREDIT SUISSE | Lorenzo Biasio |
| Morgan Stanley | |
| JPMorgan Chase | |
| Guggenheim | |
| Bryan, Garnier & Co. | |
| Deutsche Bank Securities | |
| DEUTSCHE BANK | Emmanuel Papadakis |
| Liberum Capital | |
| HSBC | Stephen McGarry |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
| BANK OF AMERICA (BOFA) | Sachin Jain |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- Consensus Novo Nordisk A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition